Chemeq founder plans $5m IPO

22/09/2015 - 16:03

Bookmark

Save articles for future reference.

A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options